Prof Nadey S Hakim, GCSJ, MD, PhD, FRCS, FRCSI, FACS, FICS(Hon), FASMBS, FIMSA(Hon)
President's Envoy, Imperial College . Chevalier de la Legion d'Honneur 2016. Vice President of the International Medical Sciences Academy. Surgical Director of the Transplant Unit at Imperial College Healthcare NHS Trust London 1995-2015. Max Thorek Professor of Surgery. Adjunct Professor of Transplantation Surgery. Particular interest in kidney and pancreas transplantation and bariatric surgery. Surgical training Guy’s Hospital. PhD in small bowel transplantation from University College London. Completed a Gastrointestinal Fellowship at the Mayo Clinic and a multiorgan transplant fellowship at the University of Minnesota. Editor in Chief of International Surgery. Member of the Kidney-Pancreas Committee of the American Society of Transplantation (AST). Past President of the International College of Surgeons (ICS) and Past-President of the Transplantation Section of the Royal Society Medicine. Member of Council RSM. London School of Surgery Transplant Tutor. Past Honorary Secretary Royal Society of Medicine. Assessor Royal College of Surgeons of England. Past Vice President Royal Society of Medicine. Governor American College of Surgeons.
et al., 2012, Expanding the Donor Pool: Living Donor Nephrectomy in the Elderly and the Overweight, Transplantation, Vol:93, ISSN:0041-1337, Pages:1158-1165
et al., 2011, RENAL VESSEL MULTIPLICITY AND ITS IMPACT ON PERIOPERATIVE AND LONG-TERM DONOR OUTCOMES FOLLOWING LIVING-DONOR NEPHRECTOMY, Transplant International, Vol:24, ISSN:0934-0874, Pages:295-295
et al., 2011, WEIGHING UP THE EVIDENCE: DOES THE OBESE KIDNEY DONOR POSE TOO HIGH AN OPERATIVE RISK TO TAKE?, Transplant International, Vol:24, ISSN:0934-0874, Pages:24-24
et al., 2011, EXPANDING THE ENVELOPE: OLDER AGE AND ITS IMPACT ON PERIOPERATIVE AND LONG-TERM OUTCOMES FOLLOWING LIVING-DONOR NEPHRECTOMY, Transplant International, Vol:24, ISSN:0934-0874, Pages:133-133
et al., 2011, 3 Year Results of a Randomised Controlled, Steroid Sparing Trial of Campath and Tacrolimus Compared with Daclizumab, Tacrolimus and Mycophenolate Mofetil in Renal Transplantation, American Transplant Congress, WILEY-BLACKWELL, Pages:146-146, ISSN:1600-6135